G&W Laboratories

What G&W Laboratories does

G&W Laboratories, Inc. is a privately held, family-owned pharmaceutical company founded in 1919 by pharmacist Carl Greenblatt in Jersey City, New Jersey, and now headquartered in South Plainfield, New Jersey. The company develops, manufactures, and markets pharmaceutical products, with a founding specialization in suppository dosage forms that has expanded over a century into creams, ointments, gels, and liquids. As of the most recent available information, G&W employs between 501 and 1,000 people and operates pharmaceutical contract manufacturing facilities in Sellersville, Pennsylvania and Lincolnton, North Carolina — assets retained following the November 2018 sale of its extended topicals and dermatology business unit (G&W Dermatology) to private equity firm Avista Capital Partners.

The company's product and service portfolio is anchored in two retained lines: (1) its original specialty in suppository dosage forms established by the founder, and (2) contract manufacturing services offered through its two manufacturing facilities to other pharmaceutical companies. Prior to the 2018 divestiture, G&W operated a branded dermatology and extended topicals business that has since been transferred to Avista Capital Partners; the company no longer commercializes that dermatology franchise. G&W's go-to-market is conducted exclusively through US healthcare distribution channels targeting healthcare providers, pharmacies, patients, and healthcare professionals — the company's privacy policy explicitly limits product information to US residents. Pricing is not publicly disclosed, consistent with pharmaceutical products sold through prescription and institutional channels rather than direct-to-consumer pricing.

The business is governed by four generations of Greenblatt family stewardship, with Aaron Greenblatt (Pharm.D.) currently serving as CEO following his 2009 joining of the company, succeeded by Ronald Greenblatt (former CEO), Burton Greenblatt, and founder Carl Greenblatt. The company maintains a stated commitment to donating 10% of annual profits to charitable causes in education, medicine, the arts, and religion. No external institutional investors, parent companies, public listings, funding rounds, or AI/ML technology capabilities are disclosed.

Name

G&W Laboratories

Legal name

G&W Laboratories, Inc.

Website

https://gwlabs.com

Company type

Private

Founded year

1919

Operating status

Operating

Headcount range

501–1,000 employees

Short description

G&W Laboratories is a privately held, family-owned pharmaceutical manufacturer founded in 1919, specializing in suppository dosage forms and contract manufacturing of creams, ointments, gels, and liquids from facilities in Pennsylvania and North Carolina, serving US healthcare providers and patients.

Ownership category

akta.pro rank

Product category

Generic Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

akta.pro secondary industry

CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)

Keywords

• Pharmaceutical manufacturing
• Generic pharmaceuticals
• Suppository formulations
• Topical medications
• Contract manufacturing

Headquarters

HQ city

South Plainfield

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales

Distribution channels1 record

Marketing channels2 records

Core offering

G&W Laboratories develops, manufactures, and markets pharmaceutical dosage form products, with an original specialty in suppository formulations established in 1919 and an expanded portfolio of topical products including creams, ointments, gels, and liquids. The company also operates pharmaceutical contract manufacturing services from its retained facilities in Sellersville, PA and Lincolnton, NC, serving the broader pharmaceutical value chain.

Product overview

G&W Laboratories is a family-owned pharmaceutical company founded in 1919 that develops, manufactures, and markets quality pharmaceutical products. The company originally specialized in suppository dosage forms and expanded into a broader portfolio including creams, ointments, gels, and liquids. In November 2018, G&W divested its dermatology and extended topicals business unit to Avista Capital Partners. The company retains its contract manufacturing operations in Sellersville, PA and Lincolnton, NC, which serve efficiency investments in the pharmaceutical value chain.

Differentiator

Problem solved

Functional benefit

Products and services

• Suppository Dosage Form Products
• Topical Pharmaceutical Products (Creams, Ointments, Gels, Liquids)
• Pharmaceutical Contract Manufacturing Services

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators4 records

Recent moves5 records

Expansion highlights3 records

Market position

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about G&W Laboratories